Methicillin-resistant Staphylococcus aureus organism

Sample Transport
Culture ☆ Chromogenic Result

InTray® COLOREX™ MRSABiomed InTray MRSA culture media for Methicillin Resistant Staphylococcus aureus diagnostics

InTray® COLOREX™ MRSA

 

Quick Links: Specifications Detection Incubation Storage Whitepapers

Chromogenic differentiated results for surveillance and environmental testing.

Over recent years, the occurrence of hospital infections caused by methicillin resistant Staphylococcus aureus (MRSA) has been increasing steadily, representing around 20 to 55% of the isolates in Europe and in the USA. Leading cause of nosocomial infections, especially in intensive care units, the MRSA sources are either endogenous (the patient) or through cross contamination (environmental or by person to person contact). The major issue with this pathogen is its resistance to a large panel of antibiotics, among them beta-lactam antibiotics, limiting the therapeutic options for clinicians.

InTray COLOREX MRSA provides an easy-to-use, in-house, chromogenic result for surface testing and AMR surveillance.

Specifications

Product Principle
  • Combine collection, culture, result and microscopic observation in one IVD device.  
  • Highly selective prepared media in a device designed for in-vitro specimen transport and incubation.
  • Rapid presumptive-positive diagnosis without re-plating.  Intray can be placed directly on microscope stage
  • Fully enclosed cassette with Tyvek® air filtration prevents contamination and exposure, post-collection.   
Simple Convenience
  • The InTray is designed for specimen collection/ inoculation at point-of-care
  • Saves time, material cost and waste, reducing exposure to collected sample
  • Place directly on the microscope tray for observation through the cassette’s clear anti-fog window
  • Visual chromogenic differentiation
Accurate Detection

Inhibit the growth of yeasts, mold, and fungi, resulting in 91.5% specificity for the growth of Oxacillin strains.

Test Strain

ATCC #

Appearance

S. aureus BAA-1720 Pink to mauve with halo
S. aureus 25923 Inhibited
P. aeruginosa 9027 Inhibited
E. faecalis 29212 Inhibited
E. coli 25922 Inhibited
C. albicans 60193 Inhibited
Time to Result
  • 18 - 24 hours, Incubates at 37°C 
Storage
  • Extended 3 months shelf life (2-8°C) from the date of manufacture
  • Can tolerate 24 hours at controlled room temp (≤ 25˚C), with no loss in performance.
Specimen
  • Sputum
  • Blood
  • Urine
  • Pleural Fluid
  • Wounds
  • Catheters
  • Tubes
CPT Codes

87040  |  87070  |  87081  |  87088  |  87075  |  87086

Features and Benefits

SHELF-LIFE AND DURABILITY

  • Designed for durability and stackable for incubation, or 3 month storage. 
  • No re-plate or wet mount 
  • Once InTray is inoculated, no other culture preparation is required... saving time and cost. 
  • Designed for specimen collection/inoculation at point-of-care, a fully enclosed system for transport, incubation, result and microscopic observation. 
  • The sealed prepared media device is selectively formulated for accurate detection and identification of pathogens and non-pathogens
  • Visual chromogenic differentiation and/or selective production of distinctive colony growth with typical identifiable morphology 

KEY FEATURES

  • Fully enclosed cassette with air filtration system
  • Nutritive culture colony growth medium, formulated for selectivity and specificity 
  • Anaerobic or aerobic system available 

YOU'LL IMMEDIATELY EXPERIENCE A REDUCTION IN:

  • Time-to-result
  • Cost of laboratory materials 
  • Medical waste
  • Risk of exposure or contamination

Regulatory

CE Marked

FDA Registered in USA - For Research Use Only

Ordering Information

Product Qty Item #
InTray COLOREX MRSA Custom Call for Pricing

Articles and Interest

Isaac See, Yi Mu, Valerie Albrecht, Maria Karlsson, Ghinwa Dumyati, Dwight J Hardy, Mackenzie Koeck, Ruth Lynfield, Joelle Nadle, Susan M Ray, William Schaffner, Alexander J Kallen; Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure,

United States, 2005–2013, Clinical Infectious Diseases, , ciz158,